Methamphetamine use problems?
Worried about someone who is using methamphetamine? Worried about YOUR use? Researchers at CODA are conducting a voluntary research study for adults ages 18 to 65. The no-cost treatment may
New studies underway!
CODA Research is involved in two National Institute on Drug Abuse new studies. The links to these two trials are below: “Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine
Want to reduce or stop meth?
Check this out: You can call CODA Research directly for this study: 503-309-3841
Want to get and keep a meaningful job?
>UPDATE: Recruiting has closed for this study. Thank you to everyone who signed up – we look forward to sharing the study results with our CODA community. CODA Research wants
New Research trials at CODA
CODA research is excited to be participating in two new trials: CODA research is recruiting for a study of an investigational medication for individuals with opioid dependence. We are looking
Latest CODA Research Studies
The results of a CODA’s Research Department study has been accepted for publication by the peer-reviewed journal International Journal of Therapeutic Massage and Bodywork. In 2011, CODA received a $30,000
Marijuana Study
UPDATE: Thanks to everyone who expressed interest in this important study. At this time, we are no longer recruiting and are closed to enrollment. We look forward to sharing with
CODA Research at American Assoc for Treatment of Opioid Dependence
Two papers were presented by CODA Research staff at the November meeting of the American Association for Treatment of Opioid Dependence (AATOD) in Philadelphia. The first was “Impact of Readiness-to-Change
CODA explores role of nutrition assessments in improving treatment
CODA Researchers recently published a preliminary study exploring the role of nutritional assessments in treatment for opioid-dependent populations. Experts have long agreed that opioid users are at risk of poor nutritional
CODA Research co-authors publication on treatment retention
CODA research staff is a co-author of a recent publication, “Treatment Retention among Patients Randomized to Buprenorphine/Naloxone Compared to Methadone in a Multi-site Trial,” which examined treatment retention and continued
PROMIS research enters new phase
The CODA Research team is currently working on another phase of the PROMIS project. PROMIS stands for “Patient Reported Outcomes Measurement Information System” and is funded by the National Institutes